Poster co-authors13 Sep 2024 20:34
From ChatGPT re co-authors “Here’s a summary of the experience and focus areas for all co-authors of the AVA6000 study (Presentation 646P at ESMO 2024):” …
1. Christopher J. Twelves (Leeds, UK):
Role: Professor of Clinical Cancer Pharmacology and Oncology, University of Leeds.
Focus: Breast cancer, cancer pharmacology, early and late-phase clinical trials, and clinical cancer drug development. He leads research efforts in oncology at the NIHR Leeds Clinical Research Facility(Medicine Health Leeds
2. Udai Banerji (Sutton, UK):
Role: Deputy Director of the Drug Development Unit at the Institute of Cancer Research & Royal Marsden.
Focus: Early-phase clinical trials, experimental therapeutics, and targeted therapies for solid tumors, including innovative drug design
3. William D. Tap (New York, USA):
Role: Chief of Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center.
Focus: Sarcoma research, targeted therapies, clinical trials, and rare cancers. He leads efforts to develop novel treatments for sarcomas
4. Natalie Cook (Manchester, UK):
Role: Clinical Researcher, University of Manchester & Christie NHS Foundation Trust.
Focus: Early-phase oncology trials, gastrointestinal tumors, and translational medicine in solid cancers
5. T.R. Jeffry Evans (Glasgow, UK):
Role: Professor of Translational Cancer Research, University of Glasgow.
Focus: Gastrointestinal cancer, clinical trials, and targeted cancer therapies. He leads research into novel therapeutics and biomarkers
6. Ruth Plummer (Newcastle upon Tyne, UK):
Role: Professor of Experimental Cancer Medicine, Newcastle University.
Focus: Early-phase clinical trials, cancer pharmacology, and DNA repair inhibitors in cancer. She is well-known for her research in targeted cancer therapy
7. Alan Anthoney (Leeds, UK):
Role: Consultant Medical Oncologist, St. James's University Hospital.
Focus: Gastrointestinal cancers and early-phase clinical trials in chemotherapy and targeted therapies
8. Christopher Plummer (Newcastle upon Tyne, UK):
Role: Consultant Cardiologist, Freeman Hospital, Newcastle.
Focus: Cardiotoxicity associated with cancer treatments, especially in patients receiving chemotherapy. He specializes in minimizing cardiac risks in cancer patients
9. Rhonna Dawson (Manchester, UK):
Role: Researcher, University of Manchester & Christie NHS Foundation Trust.
Focus: Oncology clinical trials and new cancer treatment regimens, particularly in solid tumors
10. Paul Loadman (Bradford, UK):
Role: Professor of Drug Discovery, University of Bradford.
Focus: Drug discovery, development of tumor-targeting drugs, and pharmacokinetics of anticancer agents
11. Gezim Lahu (Baar, Switzerland):
Role: Senior Researcher in Drug Development.
Focus: Oncology drug development, pharmacokinetics, and targeted drug delivery systems
TBC ...
Sign In
Follow the stocks
